FindTrial
Sign In

Construction of multi-center adverse reaction monitoring system for Chinese medicine formulation granules based on intelligent navigation(Retrospective study)

Construction of multi-center adverse reaction monitoring system for Chinese medicine formulation granules based on intelligent navigation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025002089
Enrollment
Unknown
Registered
2025-10-28
Start date
2024-11-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Observation group:none

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inpatient medical records of patients who continuously used traditional Chinese medicine formula granules in the Second Traditional Chinese Medicine Hospital of Guangdong Province and Foshan Hospital of Chinese Medicine from January 1 2021 to December 31 2023 were selected and included in the retrospective study.

Exclusion criteria

Exclusion criteria: The medical record information is incomplete with key information such as disease diagnosis and medication status missing; cases with incomplete data those who withdraw with informed consent and those who drop out during the follow-up.

Design outcomes

Primary

MeasureTime frame
Alanine Aminotransferase, ALT;—

Secondary

MeasureTime frame
Serum Creatinine;Urinalysis;Blood routine;Electrocardiogram;Total Bilirubin, TB;Stool routine examination;Alanine Aminotransferase, AST;—

Countries

China

Contacts

Public ContactHongmei Tang

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

tanghongmei2000@163.com+86 13924022239

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026